» Journals » Eur Respir J

The European Respiratory Journal

The European Respiratory Journal is a leading scientific publication dedicated to respiratory medicine and related disciplines. It publishes high-quality research articles, reviews, and clinical studies that advance our understanding of respiratory diseases, their diagnosis, treatment, and prevention. With a focus on European research, the journal serves as a valuable resource for healthcare professionals, researchers, and students in the field of respiratory medicine.

Details
Abbr. Eur Respir J
Start 1988
End Continuing
Frequency Monthly
p-ISSN 0903-1936
e-ISSN 1399-3003
Country United Kingdom
Language English
Specialty Pulmonary Medicine
Metrics
h-index / Ranks: 256 282
SJR / Ranks: 398 3810
CiteScore / Ranks: 203 25.30
JIF / Ranks: 118 24.3
Recent Articles
11.
Jiang T, Samapati R, Klassen S, Winoto-Morbach S, Mohamed Z, Goggel R, et al.
Eur Respir J . 2025 Feb; PMID: 40015747
Background: Platelet-activating factor (PAF)-induced pulmonary endothelial barrier failure is mediated by acid sphingomyelinase (ASM) translocation to caveolae. ASM, however, lacks a transmembrane domain for anchoring inside caveolae. We hypothesized that...
12.
Guth S, Ius F, Kurzyna M
Eur Respir J . 2025 Feb; 65(2). PMID: 40015736
No abstract available.
13.
Montesi S, Khor Y
Eur Respir J . 2025 Feb; 65(2). PMID: 40015735
No abstract available.
14.
Preston I, Badesch D, Ghofrani H, Gibbs J, Gomberg-Maitland M, Hoeper M, et al.
Eur Respir J . 2025 Feb; PMID: 39978862
Background: SOTERIA (NCT04796337) is an ongoing open-label study evaluating long-term safety, tolerability, and efficacy of sotatercept in participants with pulmonary arterial hypertension (PAH). Methods: Eligible adults with PAH on stable...
15.
Saferali A, Wienecke A, Xu Z, Liu T, Sheynkman G, Hersh C, et al.
Eur Respir J . 2025 Feb; PMID: 39978861
Background: Identification of COPD disease-causing genes is an important tool for understanding why COPD develops, who is at highest COPD risk, and how new COPD treatments can be developed. Previous...
16.
Blanchard M, Imler T, Hu W, Waeber A, Solelhac G, Haba-Rubio J, et al.
Eur Respir J . 2025 Feb; PMID: 39978860
Background: Sleep apnoea specific heart rate response (ΔHR) has been identified as a promising biomarker for stratifying cardiovascular (CV) risk, and predicting positive airway pressure (PAP) benefit in obstructive sleep...
17.
Arce S, Brea Folco J, Baldasaria R
Eur Respir J . 2025 Feb; PMID: 39978859
No abstract available.
18.
Kraef C, Roen A, Podlekareva D, Bakowska E, Nemeth J, Knappik M, et al.
Eur Respir J . 2025 Feb; PMID: 39978858
Background: Tuberculosis remains the leading cause of death among people with HIV. The aim of this study was to describe the incidence of tuberculosis (TB), explore risk factors and to...
19.
Leung C, Park H, Li X, Koelwyn G, Tuong J, Vahedi S, et al.
Eur Respir J . 2025 Feb; PMID: 39978857
Background: A subset of COPD patients have high levels of eosinophils in the distal airways ("airway eosinophilia"). Objectives: To compare the gene expression of type 2 inflammation in airway epithelial...
20.
Daynes E, Evans R, Greening N, Bishop N, Yates T, Lozano-Rojas D, et al.
Eur Respir J . 2025 Feb; PMID: 39978856
Objective: Post-COVID syndrome involves prolonged symptoms with multi-system and functional impairment lasting at least 12 weeks after acute COVID-19. We aimed to determine the efficacy of exercise-based rehabilitation interventions, either...